Clinical Trial Update: A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels [Phase 2]

View source ↗

Summary

Phase 2 safety and immunogenicity study of an anthrax vaccine using three schedules and two dose levels has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax

Snippet

Sponsor: Emergent BioSolutions | Conditions: Anthrax | Phase 2 | Status: COMPLETED | Results posted: 2015-02-24